{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:48:14Z","timestamp":1792068494008,"version":"4.4.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Metakids - JelteNextGen Award","award":["2025-116"],"award-info":[{"award-number":["2025-116"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"DOI":"10.1186\/s13024-026-00975-9","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:45:57Z","timestamp":1784292357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2023-064X","authenticated-orcid":false,"given":"Stephan","family":"Kemp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorrick R. J.","family":"Jaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"975_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF01835678","volume":"68","author":"E Siemerling","year":"1923","unstructured":"Siemerling E, Creutzfeldt HG. Bronzekrankheit und sklerosierende Enzephalomyelitis. Arch Psychiat Nervenkr. 1923;68:217\u201344.","journal-title":"Arch Psychiat Nervenkr"},{"key":"975_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361:726\u201330.","journal-title":"Nature"},{"key":"975_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.101","volume":"49","author":"L Bezman","year":"2001","unstructured":"Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, et al. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 2001;49:512\u20137.","journal-title":"Ann Neurol"},{"key":"975_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/humu.1227","volume":"18","author":"S Kemp","year":"2001","unstructured":"Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, Raymond GV, et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations. Hum Mutat. 2001;18:499\u2013515.","journal-title":"Hum Mutat"},{"key":"975_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/cells11020283","volume":"11","author":"EJ Mallack","year":"2022","unstructured":"Mallack EJ, Gao K, Engelen M, Kemp S. Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy. Cells. 2022;11:283.","journal-title":"Cells"},{"key":"975_CR6","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1096\/fj.08-110866","volume":"22","author":"CW van Roermund","year":"2008","unstructured":"van Roermund CW, Visser WF, Ijlst L, van Cruchten A, Boek M, Kulik W, et al. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 2008;22:4201\u20138.","journal-title":"FASEB J"},{"key":"975_CR7","doi-asserted-by":"publisher","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","volume":"288","author":"C Wiesinger","year":"2013","unstructured":"Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J. Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem. 2013;288:19269\u201379.","journal-title":"J Biol Chem"},{"key":"975_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/j.1476-5381.2011.01435.x","volume":"164","author":"S Kemp","year":"2011","unstructured":"Kemp S, Theodoulou FL, Wanders RJ. Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance. Br J Pharmacol. 2011;164:1753\u201366.","journal-title":"Br J Pharmacol"},{"key":"975_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0006-291X(81)80142-8","volume":"102","author":"I Singh","year":"1981","unstructured":"Singh I, Moser HW, Moser AB, Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex. Biochem Biophys Res Commun. 1981;102:1223\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"975_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U","volume":"45","author":"AB Moser","year":"1999","unstructured":"Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol. 1999;45:100\u201310.","journal-title":"Ann Neurol"},{"key":"975_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrendo.2016.90","volume":"12","author":"S Kemp","year":"2016","unstructured":"Kemp S, Huffnagel IC, Linthorst GE, Wanders RJA, Engelen M. Adrenoleukodystrophy - Neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016;12:606\u201315.","journal-title":"Nat Rev Endocrinol"},{"key":"975_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","volume":"14","author":"M Engelen","year":"2014","unstructured":"Engelen M, Kemp S, Poll-The B-TT. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014;14:486.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"975_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13023-024-03105-0","volume":"19","author":"HAF Yska","year":"2024","unstructured":"Yska HAF, Engelen M, Bugiani M. The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology. Orphanet J Rare Dis. 2024;19:138.","journal-title":"Orphanet J Rare Dis"},{"key":"975_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/jc.2018-01307","volume":"104","author":"IC Huffnagel","year":"2019","unstructured":"Huffnagel IC, Laheji FK, Aziz-Bose R, Tritos NA, Marino R, Linthorst GE, et al. The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration. J Clin Endocrinol Metab. 2019;104:118\u201326.","journal-title":"J Clin Endocrinol Metab"},{"key":"975_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0002-9394(76)90498-0","volume":"82","author":"SH Wray","year":"1976","unstructured":"Wray SH, Cogan DG, Kuwabara T, Schaumburg HH, Powers JM. Adrenoleukodystrophy with disease of the eye and optic nerve. Am J Ophthalmol. 1976;82:480\u20135.","journal-title":"Am J Ophthalmol"},{"key":"975_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","volume":"99","author":"M Engelen","year":"2022","unstructured":"Engelen M, van Ballegoij WJC, Mallack EJ, Van Haren KP, K\u00f6hler W, Salsano E, et al. International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach. Neurology. 2022;99:940\u201351.","journal-title":"Neurology"},{"key":"975_CR17","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1210\/jc.2018-00920","volume":"103","author":"MO Regelmann","year":"2018","unstructured":"Regelmann MO, Kamboj MK, Miller BS, Nakamoto JM, Sarafoglou K, Shah S, et al. Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn Screen. J Clin Endocrinol Metab. 2018;103:4324\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"975_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/brain\/awy299","volume":"142","author":"IC Huffnagel","year":"2019","unstructured":"Huffnagel IC, van Ballegoij WJC, van Geel BM, Vos JMBW, Kemp S, Engelen M. Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness. Brain. 2019;142:334\u201343.","journal-title":"Brain"},{"key":"975_CR19","first-page":"3257","volume-title":"Metab. Mol. Bases Inherit. Dis","author":"HW Moser","year":"2001","unstructured":"Moser HW, Smith KD, Watkins PA, Powers JM, Moser AB. X-Linked Adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. Metab. Mol. Bases Inherit. Dis. New York: McGraw Hill; 2001. pp. 3257\u2013301."},{"key":"975_CR20","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1212\/WNL.0000000000001074","volume":"83","author":"M De Beer","year":"2014","unstructured":"De Beer M, Engelen M, Van Geel BM. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy. Neurology. 2014;83:2227\u201331.","journal-title":"Neurology"},{"key":"975_CR21","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","volume":"322","author":"P Aubourg","year":"1990","unstructured":"Aubourg P, Blanche S, Jambaqu\u00e9 I, Rocchiccioli F, Kalifa G, Naud-Saudreau C, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 1990;322:1860\u20136.","journal-title":"N Engl J Med"},{"key":"975_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","volume":"61","author":"DJ Loes","year":"2003","unstructured":"Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003;61:369\u201374.","journal-title":"Neurology"},{"key":"975_CR23","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med. 2017;377:1630\u20138.","journal-title":"N Engl J Med"},{"key":"975_CR24","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Sci (80-. 2009;326:818\u201323.","journal-title":"Sci (80"},{"key":"975_CR25","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","volume":"118","author":"WP Miller","year":"2011","unstructured":"Miller WP, Rothman SM, Nascene D, Kivisto T, DeFor TE, Ziegler RS, et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011;118:1971\u20138.","journal-title":"Blood"},{"key":"975_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/acn3.526","volume":"5","author":"EI Pierpont","year":"2018","unstructured":"Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, et al. Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy. Ann Clin Transl Neurol. 2018;5:252\u201361.","journal-title":"Ann Clin Transl Neurol"},{"key":"975_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","volume":"114","author":"BH Vogel","year":"2015","unstructured":"Vogel BH, Bradley SE, Adams DJ, D\u2019Aco K, Erbe RW, Fong C, et al. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines. Mol Genet Metab. 2015;114:599\u2013603.","journal-title":"Mol Genet Metab"},{"key":"975_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jimd.12571","volume":"46","author":"M Albersen","year":"2023","unstructured":"Albersen M, van der Beek SL, Dijkstra IME, Alders M, Barendsen RW, Bliek J, et al. Sex-specific newborn screening for X-linked adrenoleukodystrophy. J Inherit Metab Dis. 2023;46:116\u201328.","journal-title":"J Inherit Metab Dis"},{"key":"975_CR29","first-page":"100902","volume":"32","author":"H-A Chen","year":"2022","unstructured":"Chen H-A, Hsu R-H, Chen P-W, Lee N-C, Chiu P-C, Hwu W-L, et al. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan. Mol Genet Metab Rep. 2022;32:100902.","journal-title":"Mol Genet Metab Rep"},{"key":"975_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jimd.12356","volume":"44","author":"EJ Mallack","year":"2021","unstructured":"Mallack EJ, Turk BR, Yan H, Price C, Demetres M, Moser AB, et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J Inherit Metab Dis. 2021;44:728\u201339.","journal-title":"J Inherit Metab Dis"},{"key":"975_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s43856-024-00605-9","volume":"4","author":"YRJ Jaspers","year":"2024","unstructured":"Jaspers YRJ, Yska HAF, Bergner CG, Dijkstra IME, Huffnagel IC, Voermans MMC, et al. Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy. Commun Med. 2024;4:175.","journal-title":"Commun Med"},{"key":"975_CR32","doi-asserted-by":"crossref","unstructured":"Kloss A, Parisi L, Wang D, Hanus M, Golden R, Keefe K, et al. Profiling of fatty acids and lipids in animal and human tissues yields new leads for disease progression biomarkers of X-linked adrenoleukodystrophy. J Biol Chem 2026:112201.","DOI":"10.1016\/j.jbc.2026.112201"},{"key":"975_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamapediatrics.2024.6774","volume":"179","author":"CJ Billington","year":"2025","unstructured":"Billington CJ, Rayannavar A, Tryon R, Kaye T, Gupta A, Lund TC, et al. Prognostication and Biomarker Potential of C26:0 Lysophosphatidylcholine in Adrenoleukodystrophy. JAMA Pediatr. 2025;179:465\u20137.","journal-title":"JAMA Pediatr"},{"key":"975_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijns11040084","volume":"11","author":"E Bonaventura","year":"2025","unstructured":"Bonaventura E, Bruschi F, Alberti L, Antonello C, Arrigoni F, Balestriero M, et al. Newborn Screening of X-Linked Adrenoleukodystrophy in Italy: Clinical and Biochemical Outcomes from a 4-Year Pilot Study. Int J Neonatal Screen. 2025;11:84.","journal-title":"Int J Neonatal Screen"},{"key":"975_CR35","doi-asserted-by":"publisher","first-page":"e70157","DOI":"10.1002\/jimd.70157","volume":"49","author":"TC Lund","year":"2026","unstructured":"Lund TC, Miettunen K, Jaspers YRJ, Bergner C, Bonkowsky JL, Bruschi F, et al. The Grey Zone Project: Risk-Based Classification of ABCD1 Variants in X-Linked Adrenoleukodystrophy. J Inherit Metab Dis. 2026;49:e70157.","journal-title":"J Inherit Metab Dis"},{"key":"975_CR36","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ana.410160603","volume":"16","author":"HW Moser","year":"1984","unstructured":"Moser HW, Moser AE, Singh I, O\u2019Neill BP. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol. 1984;16:628\u201341.","journal-title":"Ann Neurol"},{"key":"975_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0885-4505(91)90010-I","volume":"45","author":"DJ Boles","year":"1991","unstructured":"Boles DJ, Craft DA, Padgett DA, Loria RM, Rizzo WB. Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts. Biochem Med Metab Biol. 1991;45:74\u201391.","journal-title":"Biochem Med Metab Biol"},{"key":"975_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/brain\/awt361","volume":"137","author":"M Engelen","year":"2014","unstructured":"Engelen M, Barbier M, Dijkstra IME, Sch\u00fcr R, de Bie RMA, Verhamme C, et al. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain. 2014;137:693\u2013706.","journal-title":"Brain"},{"key":"975_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-019-1008-6","volume":"14","author":"IC Huffnagel","year":"2019","unstructured":"Huffnagel IC, Dijkgraaf MGW, Janssens GE, van Weeghel M, van Geel BM, Poll-The BT, et al. Disease progression in women with X-linked adrenoleukodystrophy is slow. Orphanet J Rare Dis. 2019;14:30.","journal-title":"Orphanet J Rare Dis"},{"key":"975_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.gene.2014.04.056","volume":"544","author":"X Chen","year":"2014","unstructured":"Chen X, Chen Z, Huang D, Liu X, Gui Q, Yu S. Adult cerebral adrenoleukodystrophy and Addison\u2019s disease in a female carrier. Gene. 2014;544:248\u201351.","journal-title":"Gene"},{"key":"975_CR41","first-page":"151","volume":"111","author":"JM Powers","year":"1987","unstructured":"Powers JM, Moser HW, Moser AB, Ma CK, Elias SB, Norum RA. Pathologic findings in adrenoleukodystrophy heterozygotes. Arch Pathol Lab Med. 1987;111:151\u20133.","journal-title":"Arch Pathol Lab Med"},{"key":"975_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1399-0004.1980.tb00868.x","volume":"18","author":"W Heffungs","year":"1980","unstructured":"Heffungs W, Hameister H, Ropers HH. Addison disease and cerebral sclerosis in an apparently heterozygous girl: evidence for inactivation of the adrenoleukodystrophy locus. Clin Genet. 1980;18:184\u20138.","journal-title":"Clin Genet"},{"key":"975_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/01.wnl.0000257129.51273.73","volume":"68","author":"HH Jung","year":"2007","unstructured":"Jung HH, Wimplinger I, Jung S, Landau K, Gal A, Heppner FL. Phenotypes of female adrenoleukodystrophy. Neurology. 2007;68:960\u20131.","journal-title":"Neurology"},{"key":"975_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3892\/etm.2022.11502","volume":"24","author":"Z Li","year":"2022","unstructured":"Li Z, Lai G. X-linked adrenoleukodystrophy caused by maternal ABCD1 mutation and paternal X chromosome inactivation. Exp Ther Med. 2022;24:565.","journal-title":"Exp Ther Med"},{"key":"975_CR45","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s13760-023-02295-x","volume":"123","author":"W Jiang","year":"2023","unstructured":"Jiang W, Jin W, Zhao H, Huang D, Wu L. Initial frontal lobe involvement in adult cerebral X-linked adrenoleukodystrophy. Acta Neurol Belg. 2023;123:2259\u201368.","journal-title":"Acta Neurol Belg"},{"key":"975_CR46","first-page":"856","volume":"82","author":"SS el-Deiry","year":"1997","unstructured":"el-Deiry SS, Naidu S, Blevins LS, Ladenson PW. Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J Clin Endocrinol Metab. 1997;82:856\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"975_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/bmj.1.5170.402","volume":"1","author":"RW Penman","year":"1960","unstructured":"Penman RW. Addison\u2019s disease in association with spastic paraplegia. Br Med J. 1960;1:402.","journal-title":"Br Med J"},{"key":"975_CR48","first-page":"481","volume":"76","author":"JM Powers","year":"1974","unstructured":"Powers JM, Schaumburg HH. Adreno-leukodystrophy (sex-linked Schilder\u2019s disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am J Pathol. 1974;76:481\u201391.","journal-title":"Am J Pathol"},{"key":"975_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archneur.1975.00490510033001","volume":"32","author":"HH Schaumburg","year":"1975","unstructured":"Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson Jr. EP. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol. 1975;32:577\u201391.","journal-title":"Arch Neurol"},{"key":"975_CR50","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/24.6.59773","volume":"24","author":"AB Johnson","year":"1976","unstructured":"Johnson AB, Schaumburg HH, Powers JM. Histochemical characteristics of the striated inclusions of adrenoleukodystrophy. J Histochem Cytochem. 1976;24:725\u201330.","journal-title":"J Histochem Cytochem"},{"key":"975_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1471-4159.1976.tb01593.x","volume":"27","author":"M Igarashi","year":"1976","unstructured":"Igarashi M, Belchis D, Suzuki K. Brain gangliosides in adrenoleukodystrophy. J Neurochem. 1976;27:327\u20138.","journal-title":"J Neurochem"},{"key":"975_CR52","doi-asserted-by":"crossref","unstructured":"Moser HW, Moser AB, Frayer KK, Chen W, Schulman JD, O\u2019Neill BP, et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. 1981. Neurology 1981;51:1241\u20139.","DOI":"10.1212\/WNL.31.10.1241"},{"key":"975_CR53","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/oxfordjournals.jbchem.a133578","volume":"90","author":"S Tsuji","year":"1981","unstructured":"Tsuji S, Sano T, Ariga T, Miyatake T. Increased synthesis of hexacosanoic acid (C26:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem. 1981;90:1233\u20136.","journal-title":"J Biochem"},{"key":"975_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ymgme.2004.09.015","volume":"84","author":"S Kemp","year":"2005","unstructured":"Kemp S, Valianpour F, Denis S, Ofman R, Sanders RJ, Mooyer P, et al. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab. 2005;84:144\u201351.","journal-title":"Mol Genet Metab"},{"key":"975_CR55","first-page":"164","volume":"151","author":"FR Brown","year":"1982","unstructured":"Brown FR, Van Duyn MA, Moser AB, Schulman JD, Rizzo WB, Snyder RD, et al. Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids. Johns Hopkins Med J. 1982;151:164\u201372.","journal-title":"Johns Hopkins Med J"},{"key":"975_CR56","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1083\/jcb.149.3.707","volume":"149","author":"P Tvrdik","year":"2000","unstructured":"Tvrdik P, Westerberg R, Silve S, Asadi A, Jakobsson A, Cannon B, et al. Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J Cell Biol. 2000;149:707\u201318.","journal-title":"J Cell Biol"},{"key":"975_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.plipres.2006.01.004","volume":"45","author":"A Jakobsson","year":"2006","unstructured":"Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res. 2006;45:237\u201349.","journal-title":"Prog Lipid Res"},{"key":"975_CR58","doi-asserted-by":"publisher","first-page":"18439","DOI":"10.1073\/pnas.1005572107","volume":"107","author":"Y Ohno","year":"2010","unstructured":"Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, Igarashi Y, et al. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc Natl Acad Sci U S A. 2010;107:18439\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"975_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/emmm.201000061","volume":"2","author":"R Ofman","year":"2010","unstructured":"Ofman R, Dijkstra IME, van Roermund CWT, Burger N, Turkenburg M, van Cruchten A, et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med. 2010;2:90\u20137.","journal-title":"EMBO Mol Med"},{"key":"975_CR60","doi-asserted-by":"publisher","first-page":"20573","DOI":"10.1074\/jbc.M700568200","volume":"282","author":"Z Jia","year":"2007","unstructured":"Jia Z, Moulson CL, Pei Z, Miner JH, Watkins PA. Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem. 2007;282:20573\u201383.","journal-title":"J Biol Chem"},{"key":"975_CR61","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1152\/physrev.00051.2021","volume":"103","author":"RJA Wanders","year":"2023","unstructured":"Wanders RJA, Baes M, Ribeiro D, Ferdinandusse S, Waterham HR. The physiological functions of human peroxisomes. Physiol Rev. 2023;103:957\u20131024.","journal-title":"Physiol Rev"},{"key":"975_CR62","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI118182","volume":"96","author":"JK Ho","year":"1995","unstructured":"Ho JK, Moser H, Kishimoto Y, Hamilton JA. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest. 1995;96:1455\u201363.","journal-title":"J Clin Invest"},{"key":"975_CR63","doi-asserted-by":"publisher","first-page":"139886","DOI":"10.1016\/j.jcis.2026.139886","volume":"710","author":"MI Cabrera","year":"2026","unstructured":"Cabrera MI, De Diego-Otero Y, Yahyaoui R, Arriaga LR, Aragones JL, Llombart P. Molecular insights into sphingomyelin membrane alterations induced by very long-chain lysophospholipids. J Colloid Interface Sci. 2026;710:139886.","journal-title":"J Colloid Interface Sci"},{"key":"975_CR64","doi-asserted-by":"publisher","first-page":"e142500","DOI":"10.1172\/JCI142500","volume":"131","author":"Q Raas","year":"2021","unstructured":"Raas Q, van de Beek M-C, Forss-Petter S, Dijkstra IM, Deschiffart A, Freshner BC, et al. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy. J Clin Invest. 2021;131:e142500.","journal-title":"J Clin Invest"},{"key":"975_CR65","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.bbadis.2017.06.003","volume":"1863","author":"MC van de Beek","year":"2017","unstructured":"van de Beek MC, Ofman R, Dijkstra I, Wijburg F, Engelen M, Wanders R, et al. Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2017;1863:2255\u201365.","journal-title":"Biochim Biophys Acta"},{"key":"975_CR66","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","volume":"17","author":"S Fourcade","year":"2008","unstructured":"Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet. 2008;17:1762\u201373.","journal-title":"Hum Mol Genet"},{"key":"975_CR67","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","volume":"22","author":"J Lopez-Erauskin","year":"2013","unstructured":"Lopez-Erauskin J, Galino J, Ruiz M, Cuezva JM, Fabregat I, Cacabelos D, et al. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. Hum Mol Genet. 2013;22:3296\u2013305.","journal-title":"Hum Mol Genet"},{"key":"975_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-016-1655-9","volume":"133","author":"N Launay","year":"2017","unstructured":"Launay N, Ruiz M, Grau L, Ortega FJ, Ilieva EV, Martinez JJ, et al. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy. Acta Neuropathol. 2017;133:283\u2013301.","journal-title":"Acta Neuropathol"},{"key":"975_CR69","doi-asserted-by":"publisher","first-page":"100567","DOI":"10.1016\/j.jlr.2024.100567","volume":"65","author":"YRJ Jaspers","year":"2024","unstructured":"Jaspers YRJ, Meyer SW, Pras-Raves ML, Dijkstra IME, Wever EJM, Dane AD, et al. Four-dimensional lipidomics profiling in X-linked adrenoleukodystrophy using trapped ion mobility mass spectrometry. J Lipid Res. 2024;65:100567.","journal-title":"J Lipid Res"},{"key":"975_CR70","doi-asserted-by":"crossref","unstructured":"Fujiwara Y, Hama K, Shimozawa N, Yokoyama K. Glycosphingolipids with very long-chain fatty acids accumulate in fibroblasts from adrenoleukodystrophy patients. Int J Mol Sci 2021;22.","DOI":"10.3390\/ijms22168645"},{"key":"975_CR71","doi-asserted-by":"publisher","first-page":"e12832","DOI":"10.1002\/jimd.12832","volume":"48","author":"RM Ferrer","year":"2025","unstructured":"Ferrer RM, Jaspers YRJ, Dijkstra IME, Breeuwsma N, van Klinken J-B, Romero C, et al. Altered lipid profile and reduced neuronal support in human induced pluripotent stem cell-derived astrocytes from adrenoleukodystrophy patients. J Inherit Metab Dis. 2025;48:e12832.","journal-title":"J Inherit Metab Dis"},{"key":"975_CR72","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2152\/jmi.70.403","volume":"70","author":"K Morito","year":"2023","unstructured":"Morito K, Shimizu R, Ali H, Shimada A, Miyazaki T, Takahashi N, et al. Molecular species profiles of plasma ceramides in different clinical types of X-linked adrenoleukodystrophy. J Med Invest. 2023;70:403\u201310.","journal-title":"J Med Invest"},{"key":"975_CR73","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2019.00428","volume":"13","author":"F De\u00e1k","year":"2019","unstructured":"De\u00e1k F, Anderson RE, Fessler JL, Sherry DM. Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations. Front Cell Neurosci. 2019;13:428.","journal-title":"Front Cell Neurosci"},{"key":"975_CR74","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1194\/jlr.M400510-JLR200","volume":"46","author":"RJ Sanders","year":"2005","unstructured":"Sanders RJ, Ofman R, Valianpour F, Kemp S, Wanders RJ. Evidence for two enzymatic pathways for omega-oxidation of docosanoic acid in rat liver microsomes. J Lipid Res. 2005;46:1001\u20138.","journal-title":"J Lipid Res"},{"key":"975_CR75","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1096\/fj.07-099150","volume":"22","author":"RJ Sanders","year":"2008","unstructured":"Sanders RJ, Ofman R, Dacremont G, Wanders RJA, Kemp S. Characterization of the human \u03c9-oxidation pathway for \u03c9-hydroxy-very-long-chain fatty acids. FASEB J. 2008;22:2064\u201371.","journal-title":"FASEB J"},{"key":"975_CR76","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bbalip.2013.12.001","volume":"1841","author":"CW van Roermund","year":"2014","unstructured":"van Roermund CW, Ijlst L, Wagemans T, Wanders RJ, Waterham HR. A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. Biochim Biophys Acta. 2014;1841:563\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"975_CR77","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1128\/MCB.00192-13","volume":"33","author":"T Sassa","year":"2013","unstructured":"Sassa T, Ohno Y, Suzuki S, Nomura T, Nishioka C, Kashiwagi T, et al. Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production. Mol Cell Biol. 2013;33:2787\u201396.","journal-title":"Mol Cell Biol"},{"key":"975_CR78","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"975_CR79","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","volume":"596","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, \u017d\u00eddek A, et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596:590\u20136.","journal-title":"Nature"},{"key":"975_CR80","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.21391","volume":"63","author":"F Eichler","year":"2008","unstructured":"Eichler F, Ren J-Q, Cossoy M, Rietsch AM, Nagpal S, Moser AB, et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol. 2008;63:729\u201342.","journal-title":"Ann Neurol"},{"key":"975_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-510X(92)90028-J","volume":"110","author":"C Theda","year":"1992","unstructured":"Theda C, Moser AB, Powers JM, Moser HW. Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J Neurol Sci. 1992;110:195\u2013204.","journal-title":"J Neurol Sci"},{"key":"975_CR82","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1248\/bpb.b22-00506","volume":"45","author":"N Fujitani","year":"2022","unstructured":"Fujitani N, Saito M, Akashi T, Morita M, So T, Oka K. Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy. Biol Pharm Bull. 2022;45:1725\u20137.","journal-title":"Biol Pharm Bull"},{"key":"975_CR83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1471-4159.1993.tb03567.x","volume":"61","author":"R Wilson","year":"1993","unstructured":"Wilson R, Sargent JR. Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients. J Neurochem. 1993;61:290\u20137.","journal-title":"J Neurochem"},{"key":"975_CR84","doi-asserted-by":"crossref","unstructured":"Buda A, Forss-Petter S, Hua R, Jaspers Y, Lassnig M, Waidhofer-S\u00f6llner P, et al. ABCD1 transporter deficiency results in altered cholesterol homeostasis. Biomolecules 2023;13.","DOI":"10.3390\/biom13091333"},{"key":"975_CR85","doi-asserted-by":"publisher","first-page":"114339","DOI":"10.1016\/j.isci.2025.114339","volume":"29","author":"RM Ferrer","year":"2026","unstructured":"Ferrer RM, Jaspers YRJ, Cove\u00f1a N, Breeuwsma N, Dijkstra IME, Kempff J, et al. Evolution of the lipidome uncovers early changes in adrenoleukodystrophy human cortical and spinal organoids. IScience. 2026;29:114339.","journal-title":"IScience"},{"key":"975_CR86","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1111\/j.1471-4159.2008.05513.x","volume":"106","author":"M Khan","year":"2008","unstructured":"Khan M, Singh J, Singh I. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J Neurochem. 2008;106:1766\u201379.","journal-title":"J Neurochem"},{"key":"975_CR87","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00041433-200306000-00005","volume":"14","author":"JM Ntambi","year":"2003","unstructured":"Ntambi JM, Miyazaki M. Recent insights into stearoyl-CoA desaturase-1. Curr Opin Lipidol. 2003;14:255\u201361.","journal-title":"Curr Opin Lipidol"},{"key":"975_CR88","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s11745-004-1331-2","volume":"39","author":"JM Ntambi","year":"2004","unstructured":"Ntambi JM, Miyazaki M, Dobrzyn A. Regulation of stearoyl-CoA desaturase expression. Lipids. 2004;39:1061\u20135.","journal-title":"Lipids"},{"key":"975_CR89","doi-asserted-by":"publisher","first-page":"108917","DOI":"10.1016\/j.cbi.2019.108917","volume":"316","author":"K Kikuchi","year":"2020","unstructured":"Kikuchi K, Tsukamoto H. Stearoyl-CoA desaturase and tumorigenesis. Chem Biol Interact. 2020;316:108917.","journal-title":"Chem Biol Interact"},{"key":"975_CR90","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s10545-012-9471-4","volume":"35","author":"M Engelen","year":"2012","unstructured":"Engelen M, Schackmann MJA, Ofman R, Sanders RJ, Dijkstra IME, Houten SM, et al. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation. J Inherit Metab Dis. 2012;35:1137\u201345.","journal-title":"J Inherit Metab Dis"},{"key":"975_CR91","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbalip.2014.12.005","volume":"1851","author":"MJAA Schackmann","year":"2015","unstructured":"Schackmann MJAA, Ofman R, Dijkstra IMEE, Wanders RJAA, Kemp S. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. Biochim Biophys Acta. 2015;1851:231\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"975_CR92","doi-asserted-by":"publisher","first-page":"17753","DOI":"10.1021\/acs.jmedchem.1c00944","volume":"64","author":"JH Come","year":"2021","unstructured":"Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, et al. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. J Med Chem. 2021;64:17753\u201376.","journal-title":"J Med Chem"},{"key":"975_CR93","doi-asserted-by":"publisher","first-page":"17777","DOI":"10.1021\/acs.jmedchem.1c00948","volume":"64","author":"MJ Boyd","year":"2021","unstructured":"Boyd MJ, Collier PN, Clark MP, Deng H, Kesavan S, Ronkin SM, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64:17777\u201394.","journal-title":"J Med Chem"},{"key":"975_CR94","doi-asserted-by":"publisher","first-page":"e41013","DOI":"10.1371\/journal.pone.0041013","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Tran L, Ofman R, Brennecke J, Moser AB, Dijkstra IMEE, et al. Bezafibrate for X-linked adrenoleukodystrophy. PLoS ONE. 2012;7:e41013.","journal-title":"PLoS ONE"},{"key":"975_CR95","doi-asserted-by":"publisher","first-page":"113248","DOI":"10.1016\/j.isci.2025.113248","volume":"28","author":"JY Huang","year":"2025","unstructured":"Huang JY, Freed B, Hanus M, Keefe K, Chiang MSR, Brezzani A, et al. Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy. IScience. 2025;28:113248.","journal-title":"IScience"},{"key":"975_CR96","doi-asserted-by":"publisher","first-page":"109070","DOI":"10.1016\/j.pharmthera.2026.109070","volume":"285","author":"YRJ Jaspers","year":"2026","unstructured":"Jaspers YRJ, Dijkstra IME, Engelen M, Kemp S. C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy. Pharmacol Ther. 2026;285:109070.","journal-title":"Pharmacol Ther"},{"key":"975_CR97","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/jmedgenet-2018-105711","volume":"56","author":"N Mueller","year":"2019","unstructured":"Mueller N, Sassa T, Morales-Gonzalez S, Schneider J, Salchow DJ, Seelow D, et al. De novo mutation in ELOVL1 causes ichthyosis, acanthosis nigricans, hypomyelination, spastic paraplegia, high frequency deafness and optic atrophy. J Med Genet. 2019;56:164\u201375.","journal-title":"J Med Genet"},{"key":"975_CR98","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/jmedgenet-2017-105172","volume":"55","author":"A Kutkowska-Ka\u017amierczak","year":"2018","unstructured":"Kutkowska-Ka\u017amierczak A, Rydzanicz M, Chlebowski A, K\u0142osowska-Kosicka K, Mika A, Gruchota J, et al. Dominant ELOVL1 mutation causes neurological disorder with ichthyotic keratoderma, spasticity, hypomyelination and dysmorphic features. J Med Genet. 2018;55:408\u201314.","journal-title":"J Med Genet"},{"key":"975_CR99","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.bbadis.2016.07.006","volume":"1862","author":"CE van Engen","year":"2016","unstructured":"van Engen CE, Ofman R, Dijkstra IMEE, van Goethem TJ, Verheij E, Varin J, et al. CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids. Biochim Biophys Acta. 2016;1862:1861\u201370.","journal-title":"Biochim Biophys Acta"},{"key":"975_CR100","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1074\/jbc.M513481200","volume":"281","author":"RJ Sanders","year":"2006","unstructured":"Sanders RJ, Ofman R, Duran M, Kemp S, Wanders RJ. Omega-oxidation of very long-chain fatty acids in human liver microsomes. Implications for X-linked adrenoleukodystrophy. J Biol Chem. 2006;281:13180\u20137.","journal-title":"J Biol Chem"},{"key":"975_CR101","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","volume":"75","author":"JP Hardwick","year":"2008","unstructured":"Hardwick JP. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol. 2008;75:2263\u201375.","journal-title":"Biochem Pharmacol"},{"key":"975_CR102","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1742-4658.2010.07947.x","volume":"278","author":"RJA Wanders","year":"2011","unstructured":"Wanders RJA, Komen J, Kemp S. Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. FEBS J. 2011;278:182\u201394.","journal-title":"FEBS J"},{"key":"975_CR103","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1212\/WNL.39.11.1415","volume":"39","author":"WB Rizzo","year":"1989","unstructured":"Rizzo WB, Leshner RT, Odone A, Dammann AL, Craft DA, Jensen ME, et al. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology. 1989;39:1415\u201322.","journal-title":"Neurology"},{"key":"975_CR104","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1194\/jlr.M044586","volume":"55","author":"T Sassa","year":"2014","unstructured":"Sassa T, Wakashima T, Ohno Y, Kihara A. Lorenzo\u2019s oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid. J Lipid Res. 2014;55:524\u201330.","journal-title":"J Lipid Res"},{"key":"975_CR105","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/BF00968719","volume":"19","author":"M Rasmussen","year":"1994","unstructured":"Rasmussen M, Moser AB, Borel J, Khangoora S, Moser HW. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo\u2019s oil). Neurochem Res. 1994;19:1073\u201382.","journal-title":"Neurochem Res"},{"key":"975_CR106","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJM199309093291110","volume":"329","author":"WB Rizzo","year":"1993","unstructured":"Rizzo WB. Lorenzo\u2019s oil\u2013hope and disappointment. N Engl J Med. 1993;329:801\u20132.","journal-title":"N Engl J Med"},{"key":"975_CR107","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJM199309093291101","volume":"329","author":"P Aubourg","year":"1993","unstructured":"Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Rocchiccioli F, Cartier N, Jambaque I, et al. A two-year trial of oleic and erucic acids (Lorenzo\u2019s oil) as treatment for adrenomyeloneuropathy. N Engl J Med. 1993;329:745\u201352.","journal-title":"N Engl J Med"},{"key":"975_CR108","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jnnp.67.3.290","volume":"67","author":"BM van Geel","year":"1999","unstructured":"van Geel BM, Assies J, Haverkort EB, Koelman JH, Verbeeten B Jr., Wanders RJ, et al. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with Lorenzo\u2019s oil. J Neurol Neurosurg Psychiatry. 1999;67:290\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"975_CR109","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","volume":"62","author":"HW Moser","year":"2005","unstructured":"Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo\u2019s oil. Arch Neurol. 2005;62:1073\u201380.","journal-title":"Arch Neurol"},{"key":"975_CR110","doi-asserted-by":"crossref","unstructured":"Li C, Braaten K, Moser AB, Fallatah W, Lorentson M, Huguenin S, et al. Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy. Neurotherapeutics 2026:e00890.","DOI":"10.1016\/j.neurot.2026.e00890"},{"key":"975_CR111","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1471-4159.1991.tb02558.x","volume":"56","author":"P Sharp","year":"1991","unstructured":"Sharp P, Johnson D, Poulos A. Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain. J Neurochem. 1991;56:30\u20137.","journal-title":"J Neurochem"},{"key":"975_CR112","doi-asserted-by":"crossref","unstructured":"Kettwig M, Klemp H, Nessler S, Streit F, Kr\u00e4tzner R, Rosewich H, et al. Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1tm1Kds mice and X-linked adrenoleukodystrophy patients. J Inherit Metab Dis 2021.","DOI":"10.1002\/jimd.12389"},{"key":"975_CR113","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1194\/jlr.M002329","volume":"51","author":"M Khan","year":"2010","unstructured":"Khan M, Singh J, Gilg AG, Uto T, Singh I. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res. 2010;51:1685\u201395.","journal-title":"J Lipid Res"},{"key":"975_CR114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2003.08.013","volume":"14","author":"AS Paintlia","year":"2003","unstructured":"Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis. 2003;14:425\u201339.","journal-title":"Neurobiol Dis"},{"key":"975_CR115","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1471-4159.1998.71010078.x","volume":"71","author":"M Khan","year":"1998","unstructured":"Khan M, Pahan K, Singh AK, Singh I. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem. 1998;71:78\u201387.","journal-title":"J Neurochem"},{"key":"975_CR116","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/hmg\/ddi140","volume":"14","author":"M Asheuer","year":"2005","unstructured":"Asheuer M, Bieche I, Laurendeau I, Moser A, Hainque B, Vidaud M, et al. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum Mol Genet. 2005;14:1293\u2013303.","journal-title":"Hum Mol Genet"},{"key":"975_CR117","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1073\/pnas.1217611110","volume":"110","author":"R Volmer","year":"2013","unstructured":"Volmer R, van der Ploeg K, Ron D. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proc Natl Acad Sci U S A. 2013;110:4628\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"975_CR118","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","volume":"599","author":"KA Guttenplan","year":"2021","unstructured":"Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599:102\u20137.","journal-title":"Nature"},{"key":"975_CR119","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.90926.2008","volume":"297","author":"T-Y Chang","year":"2009","unstructured":"Chang T-Y, Li B-L, Chang CCY, Urano Y. Acyl-coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab. 2009;297:E1\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"975_CR120","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.4155\/fmc.15.161","volume":"7","author":"Y Shibuya","year":"2015","unstructured":"Shibuya Y, Chang CC, Chang T-Y. ACAT1\/SOAT1 as a therapeutic target for Alzheimer\u2019s disease. Future Med Chem. 2015;7:2451\u201367.","journal-title":"Future Med Chem"},{"key":"975_CR121","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12974-023-02700-5","volume":"20","author":"SAH Zaidi","year":"2023","unstructured":"Zaidi SAH, Lemtalsi T, Xu Z, Santana I, Sandow P, Labazi L, et al. Role of acyl-coenzyme A: cholesterol transferase 1 (ACAT1) in retinal neovascularization. J Neuroinflammation. 2023;20:14.","journal-title":"J Neuroinflammation"},{"key":"975_CR122","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1038\/ncomms13129","volume":"7","author":"J Jang","year":"2016","unstructured":"Jang J, Park S, Jin Hur H, Cho H-J, Hwang I, Pyo Kang Y, et al. 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome. Nat Commun. 2016;7:13129.","journal-title":"Nat Commun"},{"key":"975_CR123","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.27117","volume":"97","author":"E Hashemi","year":"2025","unstructured":"Hashemi E, Srivastava IN, Aguirre A, Yoseph ET, Kaushal E, Awani A, et al. A Novel Mouse Model for Cerebral Inflammatory Demyelination in X-Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets. Ann Neurol. 2025;97:296\u2013312.","journal-title":"Ann Neurol"},{"key":"975_CR124","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00415-003-0189-y","volume":"250","author":"E Mayatepek","year":"2003","unstructured":"Mayatepek E, Baumann M, Meissner T, Hanefeld F, Korenke GC. Role of leukotrienes as indicators of the inflammatory demyelinating reaction in x-linked cerebral adrenoleukodystrophy. J Neurol. 2003;250:1259\u201360.","journal-title":"J Neurol"},{"key":"975_CR125","doi-asserted-by":"crossref","unstructured":"Signorini C, De Felice C, Durand T, Galano J-M, Oger C, Leoncini S, et al. Isoprostanoid plasma levels are relevant to cerebral adrenoleukodystrophy disease. Life (Basel, Switzerland). 2022;12.","DOI":"10.3390\/life12020146"},{"key":"975_CR126","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","volume":"64","author":"JM Powers","year":"2005","unstructured":"Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol. 2005;64:1067\u201379.","journal-title":"J Neuropathol Exp Neurol"},{"key":"975_CR127","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12974-022-02664-y","volume":"19","author":"B Zierfuss","year":"2022","unstructured":"Zierfuss B, Buda A, Villoria-Gonz\u00e1lez A, Logist M, Fabjan J, Parzer P, et al. Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness. J Neuroinflammation. 2022;19:305.","journal-title":"J Neuroinflammation"},{"key":"975_CR128","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cmet.2023.03.022","volume":"35","author":"H-L Chung","year":"2023","unstructured":"Chung H-L, Ye Q, Park Y-J, Zuo Z, Mok J-W, Kanca O, et al. Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation. Cell Metab. 2023;35:855\u2013e8745.","journal-title":"Cell Metab"},{"key":"975_CR129","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/glia.23598","volume":"67","author":"CG Bergner","year":"2019","unstructured":"Bergner CG, van der Meer F, Winkler A, Wrzos C, T\u00fcrkmen M, Valizada E, et al. Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia. 2019;67:1196\u2013209.","journal-title":"Glia"},{"key":"975_CR130","doi-asserted-by":"crossref","unstructured":"Bergner CG, Genc N, Hametner S, Franz J, van der Meer F, Mitkovski M, et al. Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis. Glia; 2021.","DOI":"10.1002\/glia.24042"},{"key":"975_CR131","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00401-011-0836-9","volume":"122","author":"J Kou","year":"2011","unstructured":"Kou J, Kovacs GG, H\u00f6ftberger R, Kulik W, Brodde A, Forss-Petter S, et al. Peroxisomal alterations in Alzheimer\u2019s disease. Acta Neuropathol. 2011;122:271\u201383.","journal-title":"Acta Neuropathol"},{"key":"975_CR132","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1471-4159.2010.07070.x","volume":"116","author":"MOW Grimm","year":"2011","unstructured":"Grimm MOW, Kuchenbecker J, Rothhaar TL, Gr\u00f6sgen S, Hundsd\u00f6rfer B, Burg VK, et al. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer\u2019s disease. J Neurochem. 2011;116:916\u201325.","journal-title":"J Neurochem"},{"key":"975_CR133","doi-asserted-by":"crossref","unstructured":"Nemeth CL, Sisman M, Zhang J, Shin H-G, Li X, Turk B, et al. Evidence of iron accumulation in cerebral adrenoleukodystrophy: a potential novel disease mechanism. Ann Clin Transl Neurol; 2026.","DOI":"10.1002\/acn3.70346"},{"key":"975_CR134","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.freeradbiomed.2025.10.289","volume":"242","author":"LM Marten","year":"2026","unstructured":"Marten LM, L\u00fcttgens MS, Bere\u010di\u0107 B, Tiburcy M, Br\u00fcser C, Gupta S, et al. Mitochondrial dysfunction and impaired oxidative stress defense as potential trigger of cerebral X-linked adrenoleukodystrophy. Free Radic Biol Med. 2026;242:654\u201366.","journal-title":"Free Radic Biol Med"},{"key":"975_CR135","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ecl.2016.01.003","volume":"45","author":"E Burtman","year":"2016","unstructured":"Burtman E, Regelmann MO. Endocrine Dysfunction in X-Linked Adrenoleukodystrophy. Endocrinol Metab Clin North Am. 2016;45:295\u2013309.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"975_CR136","first-page":"353","volume":"3","author":"JM Powers","year":"1980","unstructured":"Powers JM, Schaumburg HH, Johnson AB, Raine CS. A correlative study of the adrenal cortex in adrenoleukodystrophy - evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol. 1980;3:353\u201376.","journal-title":"Invest Cell Pathol"},{"key":"975_CR137","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI113292","volume":"81","author":"RW Whitcomb","year":"1988","unstructured":"Whitcomb RW, Linehan WM, Knazek RA. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest. 1988;81:185\u20138.","journal-title":"J Clin Invest"},{"key":"975_CR138","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","volume":"59","author":"JM Powers","year":"2000","unstructured":"Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol. 2000;59:89\u2013102.","journal-title":"J Neuropathol Exp Neurol"},{"key":"975_CR139","doi-asserted-by":"publisher","first-page":"e70121","DOI":"10.1002\/jimd.70121","volume":"49","author":"SIW van de Stadt","year":"2026","unstructured":"van de Stadt SIW, Wessel AMA, Langeveld M, Engelen M, Sjouke B. Sexual Dysfunction and Its Relationship With Hypogonadism and Myelopathy in Male Patients With X-Linked Adrenoleukodystrophy. J Inherit Metab Dis. 2026;49:e70121.","journal-title":"J Inherit Metab Dis"},{"key":"975_CR140","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0046-8177(82)80093-2","volume":"13","author":"JM Powers","year":"1982","unstructured":"Powers JM, Moser HW, Moser AB, Schaumburg HH. Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis. Hum Pathol. 1982;13:1013\u20139.","journal-title":"Hum Pathol"},{"key":"975_CR141","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpeds.2004.10.067","volume":"146","author":"P Dubey","year":"2005","unstructured":"Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr. 2005;146:528\u201332.","journal-title":"J Pediatr"},{"key":"975_CR142","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2019.04.021","volume":"211","author":"L Eng","year":"2019","unstructured":"Eng L, Regelmann MO. Early onset primary adrenal insufficiency in males with adrenoleukodystrophy: case series and literature review. J Pediatr. 2019;211:211\u20134.","journal-title":"J Pediatr"},{"key":"975_CR143","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/bmt.2012.33","volume":"47","author":"A Petryk","year":"2012","unstructured":"Petryk A, Polgreen LE, Chahla S, Miller W, Orchard PJ. No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy. Bone Marrow Transpl. 2012;47:1377\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"975_CR144","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R","volume":"49","author":"BM van Geel","year":"2001","unstructured":"van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol. 2001;49:186\u201394.","journal-title":"Ann Neurol"},{"key":"975_CR145","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jnen\/60.5.493","volume":"60","author":"JM Powers","year":"2001","unstructured":"Powers JM, DeCiero DP, Cox C, Richfield EK, Ito M, Moser AB, et al. The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. J Neuropathol Exp Neurol. 2001;60:493\u2013501.","journal-title":"J Neuropathol Exp Neurol"},{"key":"975_CR146","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ana.25085","volume":"82","author":"Y Gong","year":"2017","unstructured":"Gong Y, Sasidharan N, Laheji F, Frosch M, Musolino P, Tanzi R, et al. Microglial dysfunction as a key pathological change in adrenomyeloneuropathy. Ann Neurol. 2017;82:813\u201327.","journal-title":"Ann Neurol"},{"key":"975_CR147","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10545-014-9797-1","volume":"38","author":"BM van Geel","year":"2015","unstructured":"van Geel BM, Poll-The BT, Verrips A, Boelens J-J, Kemp S, Engelen M. Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study. J Inherit Metab Dis. 2015;38:359\u201361.","journal-title":"J Inherit Metab Dis"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00975-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:02:09Z","timestamp":1792065729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00975-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":147,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00975-9","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"66"}}